Journal
Blood Advances
Publication Date
12-12-2023
Volume
7
Issue
23
First Page
7295
Last Page
7303
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2023011205
Rights and Permissions
Desai SH, Spinner MA, Evens AM, Sykorova A, Bachanova V, Goyal G, Kahl B, Dorritie K, Azzi J, Kenkre VP, Chang C, Michalka J, Ansell SM, Fusco B, Sumransub N, Hatic H, Saba R, Ibrahim U, Harris EI, Shah H, Wagner-Johnston N, Arai S, Nowakowski GS, Mocikova H, Jagadeesh D, Blum KA, Diefenbach C, Iyengar S, Rappazzo KC, Baidoun F, Choi Y, Prochazka V, Advani RH, Micallef I. Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era. Blood Adv. 2023 Dec 12;7(23):7295-7303. doi: 10.1182/bloodadvances.2023011205. © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Recommended Citation
Desai, Sanjal H; Kahl, Brad; Saba, Raya; and et al., "Overall survival of patients with cHL who progress after autologous stem cell transplant: Results in the novel agent era." Blood Advances. 7, 23. 7295 - 7303. (2023).
https://digitalcommons.wustl.edu/oa_4/2995
Additional Links
Supplemental material is available for this article at publisher site.
